Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

0.4710
-0.0277-5.55%
Post-market: 0.47700.0060+1.27%19:59 EDT
Volume:195.12K
Turnover:92.19K
Market Cap:4.63M
PE:-0.03
High:0.4986
Open:0.4974
Low:0.4610
Close:0.4987
52wk High:49.25
52wk Low:0.4600
Shares:9.83M
Float Shares:9.76M
Volume Ratio:0.74
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.6157
EPS(LYR):-371.2241
ROE:-161.86%
ROA:-70.14%
PB:0.49
PE(LYR):0.00

Loading ...

Mar 19, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 11, 2021

Major Issues Report

8-K - Current report
Dec 30, 2020

Major Issues Report

8-K - Current report
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 19, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 03, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 03, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 14, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 01, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 13, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 22, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 17, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 16, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 07, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 07, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals